Literature DB >> 23550054

Grapefruit-medication interactions.

David J Greenblatt, Hartmut Derendorf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23550054      PMCID： PMC3612155          DOI： 10.1503/cmaj.113-2109

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Adverse drug event monitoring at the Food and Drug Administration.

Authors:  Syed Rizwanuddin Ahmad
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

Review 2.  Limitations and strengths of spontaneous reports data.

Authors:  S A Goldman
Journal:  Clin Ther       Date:  1998       Impact factor: 3.393

Review 3.  Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Authors:  David G Bailey; George Dresser; J Malcolm O Arnold
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

4.  Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-23

Review 5.  The effect of grapefruit juice on drug disposition.

Authors:  Michael J Hanley; Paul Cancalon; Wilbur W Widmer; David J Greenblatt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01-22       Impact factor: 4.481

Review 6.  Grapefruit-drug interactions: can interactions with drugs be avoided?

Authors:  S U Mertens-Talcott; I Zadezensky; W V De Castro; H Derendorf; V Butterweck
Journal:  J Clin Pharmacol       Date:  2006-12       Impact factor: 3.126

7.  Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily.

Authors:  Patrick Reddy; David Ellington; Yiliang Zhu; Immo Zdrojewski; Sarah J Parent; Jerold S Harmatz; Hartmut Derendorf; David J Greenblatt; Kevin Browne
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335
  7 in total
  1 in total

1.  Grapefruit-medication interactions.

Authors:  David G Bailey
Journal:  CMAJ       Date:  2013-04-02       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.